INTRODUCTION
The mission of the Agency for Toxic Substances and Disease Registry (ATSDR) is to prevent or mitigate adverse human health effects and diminished quality oflife resulting from exposure to hazardous substances in the environment. One of ATSDR's mandates is to develop toxicological profiles for chemicals found at hazar(lous waste sites. To determine the levels of sig nificant human exposure to a given chemical and asso ciated health effects, the profiles examine and interpret available toxicological and epidemiological data. Using data from the studies compiled in toxicological profiles, ATSDR derives minimal risk levels (MRLs).
An MRL is defined as "an estimate of the daily hu man exposure to a substance that is likely to be without an appreciable risk of adverse, noncancer effects over a specified duration of exposure" (ATSDR, 1992a) . MRLs provide health professionals with a concept of exposure levels at which adverse health effects are not expected in human populations living in the vicinity of hazard ous waste sites or chemical emissions. MRLs are de rived for inhalation and oral exposures. For each route of exposure, MRLs can be derived for acute (up to 14 days), intermediate (15-364 days) , and chronic (365 days or more) durations. MRLs are derived from the most sensitive end point for the exposure period which may be either the highest no-observed-adverse-effect level (NOAEL) or the lowest-observed-adverse-effect level (LOAEL) . Human data are preferred; however, human equivalent levels can be derived based on ani mal exposure. The formula for derivation of an oral MRLis MRL = NOAEL (LOAEL) (UF X MF) MRL = minimal risk level (mg/kg/day) NOAEL = no-observed-adverse-effect level (mg/kg/ day) LOAEL = lowest-observed-adverse-effect level (mg/kg/ day) UF = uncertainty factor (unitless) MF = modifying factor (unitless).
UFs are used to account for uncertainties associated with extrapolation from a LOAEL to a NOAEL and from animal to human data, and with adjustments for intraspecies variability. The concept was developed years ago for the acceptable daily intake (ADI) calcula tions (Dourson and Stara, 1983) and is also used for the reference dose (RID) derivation by U.S. Environmental Protection Agency (EPA) (Barnes and Dourson, 1988) . The basis for the approach have been described and investigated by others (Calabrese, 1985; Calabrese et at., 1992; Calabrese and Gilbert 1993; Dourson et al., 1992; Dourson and Stara, 1983; Hattis et al., 1987; Hartley and Ohanian, 1988; Renwick, 1991; Zielhuis and Vanider Kreek, 1979) .
UFs with default values of 10 are usually used for all three of the previously cited categories of extrapola tion. A factor of 10 is used for a LOAEL, if a NOAEL was not identified, to move the dose level of the LOAEL into the range of a plausible NOAEL. This adjustment is supported by analyses of several chemicals for which at least one experimental NOAEL and LOAEL were available. These analyses indicated that dividing the lowest LOAEL by a factor of 10 usually yields a value less than the experimental NOAEL (Dourson and Stara, 1983; EPA, 1989) .
Although humans are qualitatively similar to other animals with respect to health outcomes following ex posures, interspecies differences do exist. UFs of 10 have been used to compensate for the uncertainties surrounding. these differences. Dourson and Stara (1983) supported the use and selection of this uncer tainty factor based on empirical evidence in the litera ture suggesting that the 10-fold reduction in animal dose is sufficient to extrapolate to the corresponding human dose (e.g., a NOAEL).
Conditions that may enhance susceptibility to ad verse health effects include age, sex, genetic composi tion, nutritional status, and preexisting disease condi tions. UFs of 10 are usually used to derive MRLs pro tective of these sensitive subpopulations. Following an extensive literature review, Calabrese (1985) con cluded that the commonly used UF of 10 seemed to provide protection for 80 to 95% of the human popula tion.
Combining UFs without further evaluation can lead to overestimation of the actual risk. For example, if 2 factors of 10 are multiplied and each factor encom passes an extrapolation at the 95% level, the product will result in an estimate that is more conservative than the 95% level (i.e., in the direction of the 99% level or greater). To obtain a more reasonable estimate ofthe ADI associated with exposure to a specific chemi cal, a departure from the standard approach was intro duced if the database allowed the health assessors to do so (Dourson and Stara, 1983) . On a case-by-case basis, the EPA Reference Dose Workgroup (Dourson, 1994) and the ATSDR Interagency MRL Workgroup have also deliberated and agreed on certain adjust ments to the UFs. Examples ofUFs lower than 10 used in special circumstances by ATSDR are discussed in this paper.
RESULTS AND DISCUSSION
UF for "minimal" LOAELs. In the default method ology of ATSDR (1992a), an UF of 1 is used when an MRL is based on a NOAEL. An UF of 10 is applied when an MRL is based on a less-serious LOAEL. A less-serious LOAEL can be defined as changes that will prevent an organ or organ system from functioning in a normal manner but will not necessarily lead to the inability of the whole organism to function normally (e.g., focal necrosis or fatty degeneration of the liver, epithelial hyperplasia of the bile duct). Serious LOAELs are defined as effects that prevent the organ ism from functioning normally (e.g., death, coma, sei zures, extensive necrosis, abortion, and skeletovisceral defects of development). MRLs are never based on seri ous LOAELs (ATSDR, 1995) .
Certain effects are considered physiological (e.g., glu tathione depletion is not a toxic effect, but rather a biochemical event in the physiological pathway of bio degradation of toxic chemicals), adaptive (e.g., liver en largement may result from stimulation in the activity of hepatic mixed-function oxidases and from the de novo protein synthesis in the smooth endoplastic retic ulum), or otherwise not adverse (e.g., decreased body weight may be caused by reduced food consumption resulting from unpalatability of the chemical mixed in food). Although some biochemical changes are not toxic effects per se, they may be components in the sequence of events that leads to toxicity. In recognition of these subtle differences, the ATSDR MRL Workgroup adopted a minimal adverse effects category. Minimal effects are those that reduce the capacity of an organ or organ system to absorb additional toxic stress but will not necessarily lead to the inability of the organ or organ system to function normally (Durkin, 1995) . For example, slight methemoglobinemia will reduce the oxygen carrying capacity of the blood, but will not necessarily lead to the inability of the blood to supply sufficient oxygen to the body.
The workgroup conducts a careful evaluation of the adversity or nonadversity of each effect. It is, however, recognized that a NOAEL will depend on the sensitiv ity of the technique used in the particular study. New methods enable detection of subtle changes that were not recognized in older studies. Thus, effects in newer studies are often well below a previously identified NOAEL, and additional scientific judgment is needed to determine their adversity, or lack of adversity.
Since Neurological / neurobehavioral effects. The nervous system has been recognized as a target of toxicity for many chemicals. In recent years, an effort has been made to detect early signs of toxic effects, and many new methods have been developed to assess the health risks associated with exposure. However, because of the vast number of methods available, the comparabil ity of results is sometimes difficult (WHO, 1986a) . Ad verse health effects induced by chemicals in nervous system function or behavioral performance are identi fied in animal studies by means of behavioral testing (e.g., respondent and operant behavior), clinical/neuro physiological assessment (e.g., EMG, EEG, EKG), mor phological examination (e.g., light and electron micros copy), and biochemical and neuroendocrinological test ing (e.g., neurotransmitters, DNA, RNA, protein synthesis). Human studies, especially in occupational settings, however, must rely heavily on noninvasive methods to evaluate health effects. Therefore, subjec tive reports of adverse health effects are often the only indication of toxicity caused by chemicals in the work place.
An acute inhalation MRL of 3 ppm for toluene was based on data from an occupational study (Baelum et al., 1985) . In this study, a group of workers with past exposure to solvents and a matched control group of workers were used to study neurological effects oftolu ene. Both groups of subjects were exposed either to 100 ppm toluene for 6 hr or to clean air. All exposed individuals were subjected to a neurobehavioral test battery and the results were compared with the results obtained from the same individuals following exposure to clean air. No difference in results was found between the group with past exposure to solvents and the con trols. However, acute exposure to toluene caused sub jective symptoms in all individuals (increased fatigue, sleepiness, headache, mucous membrane irritation) and decreased performances on 4 ofthe 10 neurobehav ioral tests. Three of the tests pertained to visual perse verance. The fourth test affected was the simple peg board test ofvisuomotor function, where the effect was noted in the occupationally preexposed workers to a greater extent than the controls. The effects were con sidered by the ATSDR MRL workgroup to be minimal primarily because of their subjectivity and reversi bility.
Similarly, subjective symptoms, including fatigue, recent short-term memory problems, concentration dif ficulties, and mood lability, were reported by printers chronically exposed to toluene (Orbaek and Nise, 1989) . However, the results of psychometric tests were con founded by differences between the exposed and control groups on the synonyms' test performance and by alco hol consumption rates. Because of these confounders, the reported effects were classified as minimal and an UF of 3 for a LOAEL to NOAEL extrapolation was used to derive a chronic duration inhalation MRL of 1 ppm.
A chronic duration inhalation MRL of 0.3 ppm for carbon disulfide (CS 2 ) was based on the Johnson et al. (1983) study. Exposed workers were divided into one of three exposure groups having median exposure lev els of 1.0, 4.1, or 7.6 ppm CS 2 (average CS 2 exposure concentration for all of the exposed workers was 7.3 ppm). Results of electrodiagnostic tests (nerve conduc tion velocity measurements) were compared between a comparison group (median CS 2 , 0.2 ppm) and the total CS 2 exposure group as well as to each individual expo sure group. A statistically significant reduction in nerve conduction velocities (NCVs) was found in the high-exposure group and in the exposed group as a whole when compared to controls. The results were indicative ofa potential trend; however, the NCVs were still within the range ofclinically normal values. There fore, the MRL workgroup considered the effect minimal and applied an UF of 3 to the LOAEL of 7.6 ppm for LOAEL to NOAEL extrapolation, rather than the de fault value of 10.
Another type of nervous system effect is neurotrans mission-associated toxicity. The evaluation of nerve terminal function is rather complex and may include neurotransmitter synthesis and degradation, transport and release, binding, and regulation by ion channels and cyclic nucleotides. However, most chemically in duced effects on neurotransmitters are considered short-term interactions that are readily reversible, al though exceptions have been reported (Anthony and Graham, 1991 ).
An intermediate duration oral MRL of 0.02 mg/kg/ day for toluene was derived based on a 28-day drinking water study in mice (Hsieh et al., 1990) . At a dose level of 5 mg/kg/day, the authors observed increases in the levels of dopamine, norepinephrine, and serotonin in the hypothalamus. Other areas of the brain were af fected at higher exposure levels. Effects on mood and emotional state and, possibly, on aggressive behavior were expected. However, no clinical effects were re ported in exposed animals. Because of the low clinical significance and potential ease in reversibility, these effects were interpreted as minimal and an UF of 3 was used for the MRL derivation.
Hepatic effects. A vast number of techniques have been developed to detect adverse health effects on the liver, the most common target organ of toxic chemicals after oral exposure. The effects may vary from clinical signs offunctional failure to histopathological evidence of distinct changes to more subtle enzymatic and sub cellular changes. There is a fine line between effects considered not adverse and those that might be consid ered minimal, according to the definition cited pre viously. Following are examples of the workgroup deci sions on these issues.
An acute duration inhalation MRL of 0.2 ppm for carbon tetrachloride was derived using a LOAEL of 50 ppm, which described elevated serum alanine trans ferase (ALT) levels in rats exposed for 4 days, 6 hr/day (David et al., 1981) . This LOAEL was supported by histopathology in another experiment described in the David et al. (1981) paper: rats were exposed to 100 ppm carbon tetrachloride or more for 4 weeks (intermediate duration). The changes noted included altered liver gly cogen distribution, hepatocyte steatosis, hydropic de generation, and mild focal necrosis. The LOAEL of 50 ppm was also supported in general by the acute dura tion database for carbon tetrachloride which reported hepatic LOAELs in the range of 100-180 ppm (ATSDR, 1994a) . Because the changes could be classified as mild, even after prolonged exposure to higher levels, the workgroup decided to assign an UF of 3 for LOAEL to NOAEL extrapolation. An UF of 3 was also used to derive an acute duration oral MRL of 0.02 mg/kg/day for carbon tetrachloride. When rats were exposed by gavage to 5 mg/kg/day car bon tetrachloride for 10 days, centrilobular vacuolar degeneration was observed (Smialowicz et al., 1991) . No biochemical changes indicative of liver damage were detected at this exposure level. However, hepato toxicity increased in a dose-related manner. Hepatocel lular necrosis accompanied by elevated serum alanine and aspartate aminotransferases was found at the mid level doses. Cytoplasmic vacuoles frequently appear in hepatocytes following assault from hepatotoxic chemi cals. They represent early signs of toxicity indicative of inhibitory effects of these chemicals on protein syn thesis. Because of the mild character of changes de scribed in the Smialowicz et al. (1991) study, but mind ful of the potential for further damage, the workgroup used an UF of 3 for a minimal LOAEL to derive the acute oral MRL.
An intermediate duration MRL of 0.02 mg/kg/day for naphthalene was derived using data from a 90-day study in which mice were exposed by gavage once daily (7 days/week) (Shopp et al., 1984) . Serum chemistry data indicated a dose-related de'crease in blood urea nitrogen (BUN) in females at all doses tested (5.3, 53, and 133 mg/kg/day). The authors noted that although this effect was dose-related, the BUN values were within the normal range for mice. In addition, a dose dependent decrease in benzo[a]pyrene hydroxylase ac tivity was observed in both males and females. De pressed BUN values can result from overhydration, pregnancy, or liver damage. However, since neither overhydration nor pregnancy were relevant factors in these study animals, the workgroup classified de creased BUN as a minimal LOAEL for hepatotoxicity and used an UF of 3 to derive an MRL. This decision was based on the subtle nature of the effects; although the BUN values were within normal limits, they were nonetheless significantly elevated from the control val ues, perhaps indicating that the 5.3 mg/kg/day dose was near a threshold for hepatic effects.
Developmental effects. Main categories of develop mental toxicity include embryotoxicity (death), fetotox icity (altered growth), and teratogenicity (malforma tions and functional deficits) (Haddad and Winchester, 1990) . In the latter category, behavioral teratogenicity is a relatively new research field. Behavioral tests are designed to evaluate behaviors that are functions of sensory, motor, and integrative processes of the ner vous system. Behavioral changes may be very sensitive indicators of chemical exposure during nervous system development (in humans, both prenatally and postna tally). However, some authors caution that not enough evidence has accumulated to assure that the manifes tation of effects in animals and humans is similar (WHO, 1984) . Inadequate testing or interpretation of data, interspecies differences in behavioral patterns, and other variables may confound the results. An ex ample of utilizing an UF lower than 10 is the derivation of an MRL for hexachlorobenzene.
When female rats were exposed by gavage to 2.5 mg/ kg/day hexachlorobenzene in oil for 4 days, 2 weeks prior to mating, neurobehavioral effects were detected in their offspring (Goldey and Taylor, 1992) . The effects included increased negative geotaxis reflex (Postnatal Days 6 and 8), increased olfactory discriminationlhom ing (Postnatal Days 9, 10, and 11), and increased ex ploratory behavior (Postnatal Days 19 and 20, but not Days 15, 16, 17, and 18). Negative results were ob tained in other tests (e.g., acoustic startle reflex). The authors speculated that the results were indicative of hexachlorobenzene-induced (through transplacental exposure) hyperactivity in young pups. However, con current exposure through maternal milk may have re sulted in higher actual doses (Goldey, 1991) . Later studies in offspring (Postnatal Days 40 and 50) showed that the effects were reversible; no significant impact on learning ability or motor activity was detected. Therefore, the workgroup used an UF of 3 for minimal LOAEL adjustment to derive an acute duration oral MRL of 0.008 mg/kg/day for hexachlorobenzene.
Hematological effects. Blood, together with organs ofhematopoiesis, is a multifunctional system; exposure to toxic chemicals may affect its morphology and/or function. Some of the effects in blood caused by toxic chemicals include depressed cell formation, increased cell destruction, desaturation of hemoglobin, and im pairment of coagulation. Modern laboratory methods can reveal subtle changes that previously were unno ticed.
An intermediate duration oral MRL of 0.3 mg/kg/day for zinc was based on the Yadrick et al. (1989) study that evaluated women taking daily dietary zinc supple ments. A reduction (47%) in erythrocyte superoxide dis mutase (ESOD) levels (compared to preexposure levels) was detected in women taking 50 mg/day of the zinc supplement for 10 weeks. This decline was considered to be biologically significant and similar to that seen after experimental copper depletion. In sheep, copper is added to the ESOD apoenzyme at the time of erythro poiesis (Andreawartha and Caple, 1980) . Yadrick et al. (1989) proposed that if this was the case for humans, only newly formed erythrocytes would reflect a copper deficiency; therefore, a decline in ESOD activity would become apparent only after sufficient erythrocyte turn over. The authors suggested that a copper deficiency may have occurred in the study group prior to actual detection in the total erythrocyte population. The re sults, suggestive of copper-zinc interactions, are sup ported by other reports of decreased copper levels in individuals taking zinc supplements and were consid ered minimal effects (ATSDR, 1993a) . Therefore, an UF of 3 was used for minimal LOAEL to NOAEL ad justment. Consideration of the essentiality of zinc in a diet also played a role in the workgroup's deliberations.
UF for interspecies differences. Ideally, evidence of adverse effects resulting from exposure to hazardous substances should be obtained from human evalua tions. For obvious reasons, human toxicological studies are not often available. Although a number of epidemi ological studies are available that identify adverse ef fects in a defined human population, these studies often suffer from a number of uncertainties, including un known exposure levels, confounding risk factors, and concomitant exposure to other chemicals. As a result, toxicologists have had to rely heavily on animal studies to assess the potential health risks to humans. When using animal studies for MRL derivation, ATSDR se lects the most sensitive species as presented in the database.
Uncertainty factors have been used in human health risk assessments to adjust for interspecies differences. Dourson and Stara (1983) reviewed a number ofstudies comparing animal versus human toxicity for several toxicants. They concluded that, in lieu of chemical-spe cific data, an uncertainty factor of 10 was sufficient for animal to human adjustment. Although humans are considered by some investigators to be more sensitive than animals in terms of milligrams per kilogram of body weight (Dourson and Stara, 1983; Lu, 1983) , this is not always the case. Digression from the default UF of 10 is warranted when chemical-specific information is available to support such a change. The MRL Work group chose to deviate in several specific cases. Since January 1993, inhalation MRLs for titanium tetrachlo ride and oral MRLs for 1,2-dichloroethane, HMX, '}' lindane, and PCBs have been derived using UFs other than 10 for interspecies adjustment. Examples ofthese cases are discussed below (see Table 1 ).
A chronic oral MRL of 0.02 p,g/kg/day for PCBs was based on the Tryphonas et al. (1989 Tryphonas et al. ( , 1991a studies. Immunological parameters were altered in rhesus monkeys exposed chronically to doses as low as 5 p,g/ kg/day. The monkeys were administered sheep red blood cells (SRBCs) at 23 months (Tryphonas et al., 1989) and at 55 months (Tryphonas et al., 1991a) . At 23 months, a primary response to SRBCs was evoked. An anamnestic response was elicited at 55 months. In both cases, decreases in IgM and IgG levels were ob served, although the IgG response at 55 months was significant only when the overall trend was analyzed. This depressed response to both primary and secondary stimulation was seen as sufficient evidence of an ad verse effect of PCBs on the immune system of exposed monkeys. Reduced humoral antibody production is classified as a less-serious or a serious LOAEL de pending on the degree of suppression (ATSDR, 1995) . In this case, the reduction was categorized as less seri ous. Decreased immune or antibody response for a sin gle route/duration is not usually regarded as adequate evidence for identifying the immune system as a target organ system. However, when coupled with other indi cators of immune system dysfunction as supportive evi dence, these endpoints may be used for MRL deriva tion. The supporting evidence need not come from the same study (ATSDR, 1995) . Although only immuno globulins were measured at the 5 {lg/kg/day level of PCBs exposure in Tryphonas et al. (1989) , other indica tors ofimmunotoxicity (e.g., decreased phagocytic abil ity of monocytes) were found at higher doses (Trypho nas et al., 1989 (Trypho nas et al., , 1991a . Furthermore, supportive evi dence that PCBs are immunotoxic is provided by a number of other studies cited in the Toxicological Pro file for PCBs (ATSDR, 1992b) . It is believed that, simi larly to chlorinated dibenzodioxins (CDDs) and chlori nated dibenzofurans (CDFs), coplanar PCBs act through the Ah receptor mechanism. The antibody re sponse to SRBCs is the only immunological parameter consistently suppressed by halogenated aromatic hy drocarbons (PCBs, eDDs, CDFs) in various species (ATSDR, 1992b (ATSDR, , 1994c . In contrast, changes in other immunological parameters are more inconsistent among the studies. The reason for this is not clear.
Monkeys and humans are closely related species that metabolize PCBs by similar pathways. Because mon keys are very sensitive to PCBs-induced immunotoxic ity, and suppression of antibody response is consistent among species following halogenated aromatic hydro carbons exposure, an UF of 3 instead of the default value of 10 was used for MRL derivation to adjust for interspecies differences.
A chronic duration inhalation MRL of 0.0003 mg/m 3 was derived for titanium tetrachloride. Major health effects noted were dose-dependent increases in trache itis and rhinitis in male and female rats exposed to 0.1 mg/m 3 for 2 years (Lee et al., 1986; EPA, 1986) . Tracheitis increased with duration, and to a lesser de gree, with concentration. The incidences of tracheitis at the end of the 2 years were 12-20% for the low-dose group (0.1 mg/m 3 ) and 30-44% for the high-dose group (10 mg/m 3 ). Gross pathology and histopathology re vealed compound-related changes in the lungs and tho racic lymph nodes of the treated animals. The effects observed are considered a consequence of direct con tact. This results from the instability oftitanium tetra chloride in the presence of water leading to its rapid hydrolysis and subsequent generation of hydrochloric acid (ATSDR, 1994b) . The MRL Workgroup concluded that despite the direct contact mechanism, an UF of 3 instead of the default value of 10 was needed to account for possible anatomical differences of the respiratory tract between humans and animals.
An intermediate duration oral MRL of 0.05 mg/kg/ day was derived for HMX (cyclotetramethylene-tetra nitramine). This was based on a 13-week study in Fi scher rats (Everett and Maddock, 1985) . A NOAEL of 50 mg/kg/day was identified. Exposure to ;:;: 150 mg/kg/ day resulted in hepatic centrilobular cells with pale nuclei and dark cytoplasm. Additional effects observed included focal renal tubule atrophy, dilatation, and in creased kidney weights in females at 270 mg/kg/day and elevated BUN at 1500 mg/kg/day. In deliberating the MRL for HMX, the workgroup considered addi tional information. This included the fact that acute exposure data suggested that neurological effects may be more sensitive endpoints, although neurotoxicity has not been evaluated for intermediate duration expo sure. Furthermore, limited evidence suggested that rabbits are a more sensitive species (ATSDR, 1994d). As a result, an additional UF of 10 (total UF = 100 for interspecies extrapolation) was used rather than the default of 10.
UF for intraspecies differences. Similarly to inter species extrapolation, an UF of 10 is usually used to account for intraspecies differences; (i.e., human vari ability) in response to toxic chemicals. This UF was introduced to protect sensitive individuals within a population. Age, sex, genetic composition, nutritional status, and preexisting diseases may all alter suscepti bility to toxic chemicals.
Data available for some chemicals allowed for depar ture from this policy. An UF of 1 was used to derive an intermediate duration oral MRL for zinc and an acute duration inhalation MRL for metallic mercury. An UF of 3 was used to derive an acute duration inhalation MRL for acetone, an intermediate duration inhalation MRL for xylenes, an acute duration oral MRL for '}' lindane, and a chronic duration oral MRL for arsenic. The following are examples of issues the MRL Work group considered before deriving MRLs for these chem icals (Table 1) .
Infants and young children differ from adults in sev eral ways. Larger body surface area in relation to weight, higher metabolic rate and oxygen consumption, greater energy and fluid requirements, etc., may affect the infant or young child's susceptibility to chemically induced effects (WHO, 1986b) . Organs such as the liver and kidneys are not functionally developed enough to properly metabolize and excrete toxic chemicals which may lead to chemical accumulation and additional damage. Furthermore, some systems (e.g., immunolog ical, neurological) are not fully developed and are easy targets for chemical injury. The workgroup's reflectioJls on these aspects can be seen in the following example for mercury.
An acute duration inhalation MRL of 20 ng/m 3 for metallic mercury was based on the Fredriksson et al. (1992) study. In this study, newborn rats were exposed to 0.05 mg/m 3 metallic mercury for 1 hr a day on Post partum Days 11 through 17. At the age of 4 months, the exposed rats showed increased locomotor activity and decreased rearing. At 6 months, the rats needed a longer time to complete a radial arm maze. The authors concluded that exposure to metallic mercury during central nervous system (CNS) development may cause effects later in adult CNS function.
Studies of metallic mercury indicate that it is quickly absorbed by the inhalation route and its half-life in the body is within a range of several weeks (ATSDR, 1993b) . Neurotoxicity of metallic mercury has been demonstrated in adults of several species. It is known that an" extremely critical period for CNS damage is during the brain's growth spurt, the period investi gated in the Fredriksson et al. (1992) study. In support of this observation, numerous examples of toxic effects induced in developing versus mature CNS can be found in studies on lead (ATSDR, 1992c) . Therefore, the new born rats were considered as the most sensitive popula tion and an UF of 1 instead of the default value of 10 for intraspecies variability was applied in the MRL calculation.
One of the theories of aging implies that changes in gene expression or gene structure may result in altered biochemistry, physiology, and, eventually, special pa thologies of the elderly (WHO, 1993) . These changes may have a great impact on susceptibility to a chemical insult. Further, the aged population often has been subjected to previous chemical exposure, either occupa tionally or in the environment. In that case, further exposure may exceed the natural ability of the organ ism to withstand chemical injury.
When deliberating the chronic oral MRL of 0.0003 mg/kg/day for inorganic arsenic, the workgroup consid ered the preceding factors. The MRL was based on the Tseng et al. (1968) study in which a large Taiwanese population was exposed to arsenic, mainly through drinking water. An UF of 3 rather than the default value of 10 for human susceptibility was used because the database for human exposure to arsenic is large, thus, reducing the uncertainty (Crump, 1984; Gaylor, 1983) . There is a clear agreement of NOAEL and LOAEL values across human studies; in addition, the effects of arsenic increase with age indicating that the sensitive population was taken into account in the aged population of the Taiwanese study.
CONCLUSIONS
The risks to human health from exposure to chemi cals in the environment are assessed by the evaluation of substance-specific databases. Identification of NOAELs is useful to the decision-making process by guiding health assessors to levels that potentially threaten human health. The uncertainties surrounding possible dissimilar responses between animals and hu mans, variation in human susceptibility, and use of LOAELs in lieu of missing NOAELs have traditionally been accounted for by the use of UFs of 10. This ap proach has been challenged for various reasons out lined by Barnes and Dourson (1988) . Criticisms include the fact that the NOAEL-UF approach does not take into consideration the slope ofthe dose-response curve or sample size of the critical study, and questions sur rounding appropriate endpoint selection.
ATSDR as well as other agencies (e.g., EPA) have recognized these deficiencies and contend that the cur rent approach, if used in conjunction with scientific judgment, can be useful (Dourson, 1994) . For example, the issue of sample size has been discussed by Gaylor (1983) . In two hypothetical experiments of two differ ent sample sizes, he calculated a higher "safe" dose for the experiment with the smaller sample size when it should actually have been lower due to the greater de gree of uncertainty in the smaller experiment. The ATSDR MRL Workgroup took this issue into consider ation during deliberations for the inorganic arsenic oral MRL. A more plausible MRL was derived using an UF of 3 for intraspecies variation for reasons previously described that included the large study population.
Exposure to minimal LOAELs may not be deleterious in and of itself, but may provide an early warning sig nal oftoxicity. Again, as previously described, the acute duration oral MRL for carbon tetrachloride was derived from a hepatic endpoint (centrilobular vacuolar degen eration). Although this effect may be considered as mild and reversible, hepatic toxicity increased in a dose-re lated manner as evidenced by centrilobular necrosis that developed following exposure to higher doses.
The standard approach to health risk assessment us ing MRLs that were derived by the methods as de scribed in this article is intended to present to the pub lic levels of exposure that will not be associated with adverse health effects. However, health assessors are often faced with the problem of people being exposed at a higher level than MRL (or RID). For most of the environmental contaminants, there is a gap of inform a tion about the levels at which the first subtle health effects will occur in humans.
Information used for evaluating public health risks needs to be chemical-specific because dose/severity re lationship may differ for each chemical. For some chem icals, the progression from mild to severe effects is steady. For other chemicals, a sudden steep rise in the number and severity of effects may occur due to satura tion of the detoxification or elimination pathway. That is why new approaches to risk assessment, e.g., bench mark dose calculation, physiologically based pharma cokinetic (PBPK) modeling, and quantitative struc ture-activity relationships (QSAR) are being explored: ATSDR has joined the search for alternative methodol ogies to refine the strategies used in making public health decisions at hazardous waste sites byestablish ing PBPK and QSAR workgroups. They are intended to provide help in decision making on a case-by-case basis.
